Ambar Protein Industries Ltd

Ambar Protein Industries Ltd. has announced its 33rd Annual General Meeting (AGM) to be held on Wednesday, September 30, 2026, at 10:00 AM at its registered office in Ahmedabad. The meeting agenda includes the adoption of financial statements for the year ended March 31, 2026, the appointment of directors retiring by rotation, approval of remuneration for cost auditors for FY 2026-27, and approval of related party transactions under Section 188 of the Companies Act, 2013. Key related party transactions include leasing/subleasing/rent and sales of goods with Ankur Oil Industries, where common directors are partners. The proposed remuneration for cost auditors is ₹40,000.

Ambar Protein Industries Ltd has submitted its Annual Report for the Financial Year 2025-26, as per Regulation 34(1) of SEBI (LODR) Regulations, 2015. The report includes the Notice of the 33rd Annual General Meeting (AGM), scheduled for September 30, 2026. The AGM agenda includes the adoption of financial statements for the year ended March 31, 2026, and the appointment of directors retiring by rotation. Additionally, the company seeks approval for the remuneration of its Cost Auditors for FY 2026-27 and related party transactions.

Ambar Protein Industries Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors approved these results along with the Limited Review Report from the statutory auditor. Key decisions included the adoption of the Draft Directors' Report for FY25-26 and the notice for the 33rd Annual General Meeting (AGM) scheduled for September 30, 2026. The company also approved book closure dates for the AGM from September 23-30, 2026, and confirmed e-voting services via CDSL. Related party transactions concerning the sale of machinery and commission paid to non-executive directors were also approved, subject to shareholder consent at the AGM. The company reported revenue from operations of ₹14,344.84 Lakhs and a net profit of ₹375.45 Lakhs for the quarter.

Ambar Protein Industries Ltd announced that its Board of Directors met on August 14, 2026. The meeting was held at the company's registered office. The board approved the unaudited financial results for the quarter ended June 30, 2026. These results were prepared in accordance with Indian Accounting Standards (Ind AS). The statutory auditors have completed a limited review of these unaudited financial results. The company operates in a single business segment: manufacturing and selling edible oil.

Ambar Protein Industries Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results of the company. The filing also notes the company's former name, Ankur Protein Industries Limited.

Ambar Protein Industries Ltd has issued a clarification to BSE Limited regarding the recent movement in its share price. The company, formerly known as Ankur Protein Industries Ltd, addressed the stock exchange on July 4, 2026. The filing does not provide specific reasons for the price fluctuation but serves as a response to an inquiry from the exchange.

Pradeep Kumar Chunilal Khetani, belonging to the promoter group, has acquired 18,187 equity shares, representing 0.316% of the total share capital, in Ambar Protein Industries Ltd. The acquisition occurred through open market transactions on June 29th and 30th, 2026. Following this transaction, Khetani's total holding in the company has increased to 755,838 shares, constituting 13.14% of the total share capital. The company's equity share capital remains unchanged at INR 5,75,00,000.

Pradeep Kumar Chunilal Khetani has acquired 9,738 equity shares, representing 0.17% of the total share capital, in Ambar Protein Industries Ltd through open market transactions on June 25, 2026. This acquisition increases his total shareholding in the company to 737,651 shares, or 12.83% of the total voting capital. The transaction was disclosed under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The total equity share capital of the company remains unchanged at INR 5,75,00,000.

Ambar Protein Industries Ltd has announced the closure of its trading window. The company informed the Bombay Stock Exchange about this decision. The exact dates for the closure and the reason, typically related to financial results announcement or other material information disclosure, are not specified in this brief filing. Investors and stakeholders are advised to note this period during which trading of the company's shares will be restricted.

Pradeep Kumar Chunilal Khetani, a promoter group member, has acquired 13,200 equity shares, representing 0.23% of the total share capital, in Ambar Protein Industries Ltd through open market transactions on June 23, 2026. This acquisition increases his total shareholding to 727,913 shares, or 12.66% of the company's equity. The transaction was disclosed under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The company's equity share capital remains unchanged at INR 5,75,00,000.